Structures by: Ravikumar K.
Total: 373
Cytosinium-3,5-dinitrobenzoate trihydrate
C4H6N3O,C7H3N2O6,3(H2O)
CrystEngComm (2012) 14, 20 7065
a=5.0257(3)Å b=24.5327(15)Å c=13.1664(8)Å
α=90.00° β=90.462(1)° γ=90.00°
Cytosinium para amino benzoate cytosine monohydrate
C4H6N3O,C7H6NO2,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=7.3666(3)Å b=6.4615(3)Å c=36.9629(16)Å
α=90.00° β=94.462(1)° γ=90.00°
Cytosinium 4-hydroxyphenylacetate cytosine monohydrate
C4H6N3O,C8H7O3,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=14.9164(10)Å b=12.3456(8)Å c=19.9754(13)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium-2,5-dihydroxybenzoate
C4H6N3O,C7H5O4
CrystEngComm (2012) 14, 20 7065
a=10.1137(8)Å b=8.5120(7)Å c=13.9992(12)Å
α=90.00° β=110.610(1)° γ=90.00°
2,4,6-Tris(benzyloxy)-1,3,5-triazine
C24H21N3O3
Journal of Materials Chemistry (2006) 16, 5 496
a=23.4804(13)Å b=11.7367(7)Å c=7.3650(4)Å
α=90.00° β=90.00° γ=90.00°
2,4,6-tris(4-fluorobenzylamino)-1,3,5-triazine
C24H21F3N6
Journal of Materials Chemistry (2005) 15, 9 965
a=12.0367(11)Å b=20.9059(18)Å c=8.6999(8)Å
α=90.00° β=90.00° γ=90.00°
2-(2-(4,6-bis(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-1-yl) ethyl)phthalazin-1(2H)-one
C17H16N6OS2
CrystEngComm (2012) 14, 2 383
a=16.708(2)Å b=15.732(2)Å c=14.4360(10)Å
α=90.00° β=107.790(10)° γ=90.00°
2-(2-(4-chloro-6-(methylthio)-1H-pyrazolo [3,4-d]pyrimidin-1-yl)ethyl)phthalazin-1(2H)-one
C16H13ClN6OS
CrystEngComm (2012) 14, 2 383
a=9.1610(10)Å b=14.0630(10)Å c=13.1090(10)Å
α=90.00° β=102.120(10)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=18.2274(5)Å b=15.2903(4)Å c=13.9319(5)Å
α=90.00° β=108.746(3)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=9.2490(10)Å b=17.580(2)Å c=11.550(2)Å
α=90.00° β=105.110(10)° γ=90.00°
None
C16H13ClN6O3S
CrystEngComm (2012) 14, 2 383
a=13.6729(8)Å b=9.0043(6)Å c=13.8349(8)Å
α=90.00° β=90.388(5)° γ=90.00°
Dutasteride hemihydrate
2(C27H30F6N2O2),H2O
CrystEngComm (2012) 14, 7 2571
a=8.2124(7)Å b=18.5162(17)Å c=34.876(3)Å
α=90.00° β=90.00° γ=90.00°
Dutasteride chloride hydrate ethanol solvate
C27H31F6N2O2,Cl,H2O,C2H6O
CrystEngComm (2012) 14, 7 2571
a=7.9357(7)Å b=9.1050(8)Å c=11.1952(9)Å
α=73.7460(10)° β=88.6870(10)° γ=86.1930(10)°
1:1 cocrystal of Aripiprazole Phloroglucinol Hydrate
C23H27Cl2N3O2,C6H6O3,O
CrystEngComm (2016) 18, 6 1024
a=14.8405(6)Å b=10.2671(4)Å c=20.6587(9)Å
α=90° β=110.2190(10)° γ=90°
1:1 cocrystal of Aripiprazole Catechol Hydrate
C23H27Cl2N3O2,C6H6O2,0.293(O)
CrystEngComm (2016) 18, 6 1024
a=14.7513(16)Å b=9.9206(11)Å c=20.9131(17)Å
α=90° β=111.104(6)° γ=90°
1:1 cocrystal of Aripiprazole and Hydroquinone
C23H27Cl2N3O2,C6H6O2
CrystEngComm (2016) 18, 6 1024
a=6.9061(8)Å b=9.4544(11)Å c=22.484(3)Å
α=96.056(2)° β=95.355(2)° γ=100.696(2)°
1:1 cocrystal of Aripiprazole Pyrograllol Hydrate
C23H27Cl2N3O2,C6H6O3,0.256(O)
CrystEngComm (2016) 18, 6 1024
a=14.7016(11)Å b=9.9378(7)Å c=20.9827(12)Å
α=90° β=111.121(4)° γ=90°
1:1 cocrystal of Aripiprazole Resorcinol
C23H27Cl2N3O2,C6H6O2
CrystEngComm (2016) 18, 6 1024
a=14.7282(12)Å b=9.8820(8)Å c=20.8815(14)Å
α=90° β=111.174(5)° γ=90°
Olanzapine-hydroquinone-toluene form II
C17H20N4S,C6H6O2,C7H8
CrystEngComm (2017) 19, 2 355
a=9.3202(10)Å b=10.5724(12)Å c=14.7777(16)Å
α=88.561(2)° β=85.685(2)° γ=81.729(2)°
Olanzapine-hydroquinone-toluene form I
C17H20N4S,C6H6O2,C7H8
CrystEngComm (2017) 19, 2 355
a=10.6675(14)Å b=11.6121(15)Å c=13.0639(17)Å
α=72.725(2)° β=74.290(2)° γ=65.743(2)°
Moxonidine
C9H12ClN5O
CrystEngComm (2014) 16, 46 10602
a=21.293(2)Å b=7.8312(9)Å c=13.9098(16)Å
α=90.00° β=109.820(2)° γ=90.00°
Moxonidine hydrochloride monohydrate
C9H13ClN5O,Cl,H2O
CrystEngComm (2014) 16, 46 10602
a=8.5413(10)Å b=13.2793(15)Å c=24.376(3)Å
α=90.00° β=90.00° γ=90.00°
Aripiprazole hydrochloride salt
C23H28Cl2N3O2,Cl
CrystEngComm (2013) 15, 21 4321
a=10.2891(12)Å b=28.065(3)Å c=7.9247(9)Å
α=90.00° β=90.885(2)° γ=90.00°
Aripiprazole benzoate monohydrate
C23H28Cl2N3O2,C7H5O2,H2O
CrystEngComm (2013) 15, 21 4321
a=14.9688(10)Å b=9.9536(6)Å c=20.9154(14)Å
α=90.00° β=108.0040(10)° γ=90.00°
Aripiprazole-2,4-dihydoxybenzoate
C23H28Cl2N3O2,C7H5O4
CrystEngComm (2013) 15, 21 4321
a=15.1552(8)Å b=9.5732(5)Å c=21.5283(11)Å
α=90.00° β=103.8870(10)° γ=90.00°
Aripiprazole-2,5-dihydroxybenzoate hemihydrate
2(C23H28Cl2N3O2),2(C7H5O4),H2O
CrystEngComm (2013) 15, 21 4321
a=30.4165(19)Å b=9.7801(6)Å c=20.5636(13)Å
α=90.00° β=105.3190(10)° γ=90.00°
(C23H14O62),2(C4H12N5)
(C23H14O62),2(C4H12N5)
CrystEngComm (2013) 15, 22 4448
a=17.8097(8)Å b=7.9282(4)Å c=25.8018(9)Å
α=90.00° β=119.499(2)° γ=90.00°
2(C4H12N5),C23H14O62
2(C4H12N5),C23H14O62
CrystEngComm (2013) 15, 22 4448
a=7.4680(6)Å b=13.8016(11)Å c=16.2856(13)Å
α=73.334(1)° β=83.171(1)° γ=82.666(1)°
1,3-Bis(2,6-dimethyl sulfanyl-9H-purin-9-yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=16.357(3)Å b=10.062(2)Å c=13.506(3)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(4,6-dimethyl sulfanyl-1H-pyrazolo(3,4-d) pyrimidin-1- yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=9.122(5)Å b=9.560(5)Å c=14.181(5)Å
α=102.828(5)° β=102.183(5)° γ=107.820(5)°
1-(9H-carbazol-9-yl)-3-(4-methoxy-6-methylsulfanyl-1H- pyrazolo (3,4-d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5OS
CrystEngComm (2011) 13, 6 2039
a=8.5125(5)Å b=10.6289(7)Å c=11.9705(8)Å
α=70.965(3)° β=81.944(3)° γ=86.356(3)°
1-(9H-carbazol-9-yl)-3-(4,6-dimethylsulfanyl-1H-pyrazolo (3,4- d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5S2
CrystEngComm (2011) 13, 6 2039
a=10.1518(10)Å b=8.7585(9)Å c=24.492(3)Å
α=90.00° β=101.961° γ=90.00°
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4- dihydrocarbostyril)
C23H27Cl2N3O2
CrystEngComm (2012) 14, 14 4677
a=12.2626(7)Å b=13.7872(8)Å c=14.7405(9)Å
α=101.396(1)° β=108.921(1)° γ=98.847(1)°
<i>tert</i>-Butyl 4'-(4-bromophenyl)-1''-methyl-2,2''-dioxo-5'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C36H31BrN2O5
Acta Crystallographica Section C (2015) 71, 8
a=9.5268(12)Å b=13.0566(17)Å c=13.4593(17)Å
α=94.401(2)° β=97.385(2)° γ=107.762(2)°
5'-(4-Bromophenyl)-1,1''-dimethyl-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C32H25BrN2O3
Acta Crystallographica Section C (2015) 71, 8
a=9.0986(7)Å b=9.7185(7)Å c=16.5056(13)Å
α=78.9150(10)° β=75.7630(10)° γ=67.6870(10)°
<i>tert</i>-Butyl 1''-methyl-2,2''-dioxo-4'-phenyl-5'-(<i>p</i>-tolyl)-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C37H34N2O5
Acta Crystallographica Section C (2015) 71, 8
a=10.1226(9)Å b=14.3682(13)Å c=21.353(2)Å
α=90° β=91.799(2)° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate benzene monosolvate
C27H21BrO6,C6H6
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.4269(6)Å b=12.4905(8)Å c=15.1415(10)Å
α=66.5300(10)° β=76.0050(10)° γ=85.4730(10)°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate toluene monosolvate
C27H21BrO6,C7H8
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.3989(5)Å b=12.5415(7)Å c=15.2195(8)Å
α=67.4080(10)° β=76.1350(10)° γ=85.4580(10)°
1,1''-Dibenzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C44H33ClN2O3
Acta Crystallographica Section C (2015) 71, 11
a=10.1099(10)Å b=11.3367(11)Å c=17.0315(17)Å
α=74.755(2)° β=78.503(2)° γ=65.557(2)°
1''-Acetyl-1-benzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H29ClN2O4
Acta Crystallographica Section C (2015) 71, 11
a=11.9830(5)Å b=12.9260(6)Å c=21.5664(10)Å
α=76.3300(10)° β=76.5220(10)° γ=77.5530(10)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H30N2O4
Acta Crystallographica Section C (2015) 71, 11
a=9.7565(10)Å b=16.6868(16)Å c=19.9593(19)Å
α=71.653(2)° β=81.657(2)° γ=89.314(2)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione acetonitrile hemisolvate
C39H30N2O4,0.5(C2H3N)
Acta Crystallographica Section C (2015) 71, 11
a=9.6940(5)Å b=18.5810(10)Å c=20.1552(11)Å
α=114.872(2)° β=98.465(2)° γ=99.397(2)°
Thymine--pyrogallol (1/2)
C5H6N2O2,2(C6H6O3)
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9652(13)Å b=10.2125(19)Å c=12.951(2)Å
α=97.218(3)° β=99.189(3)° γ=108.549(3)°
Thymine--hydroquinone (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=14.204(3)Å b=6.9634(13)Å c=8.4505(15)Å
α=90° β=97.639(3)° γ=90°
Thymine--catechol (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9499(7)Å b=9.0237(10)Å c=26.828(3)Å
α=90° β=90° γ=90°
Thymine--catechol (1/1)
C5H6N2O2,C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9132(8)Å b=8.9917(10)Å c=36.898(4)Å
α=90° β=90° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate xylene monosolvate
C27H21BrO6,C8H10
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.2587(6)Å b=12.7841(9)Å c=15.6238(11)Å
α=66.4460(10)° β=76.6340(10)° γ=86.0300(10)°
Oxyclozanide benzene hemisolvate
C13H6Cl5NO3,0.5(C6H6)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=7.16810(8)Å b=9.28821(10)Å c=13.42132(15)Å
α=88.3124(5)° β=85.6481(5)° γ=69.7508(5)°
Oxyclozanide xylene hemisolvate
C13H6Cl5NO3,0.5(C8H10)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=7.12429(8)Å b=9.40484(11)Å c=14.27988(16)Å
α=83.7014(5)° β=80.0916(5)° γ=67.8388(4)°
Oxyclozanide toluene hemisolvate
C13H6Cl5NO3,0.5(C7H8)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=6.92017(8)Å b=9.71946(11)Å c=13.98498(17)Å
α=86.3845(5)° β=85.4687(5)° γ=65.8069(5)°
Oxyclozanide chlorobenzene hemisolvate
C13H6Cl5NO3,0.5(C6H5Cl)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1056-1063
a=6.90927(8)Å b=9.69846(10)Å c=13.97198(15)Å
α=86.5557(5)° β=85.9678(5)° γ=65.8305(5)°
N,6-Dimethyl-4-(methylsulfanyl)-3-nitro-4H-chromen-2-amine
C12H14N2O3S
Acta Crystallographica Section E (2006) 62, 5 o1961-o1963
a=10.5558(5)Å b=17.5031(8)Å c=6.9415(3)Å
α=90.00° β=101.8630(10)° γ=90.00°
1-(3-Nitrophenyl)-5-tosylperhydropyrrolo[3,4-b]pyrrole
C19H21N3O4S
Acta Crystallographica Section E (2006) 62, 5 o2045-o2047
a=7.4456(4)Å b=25.2680(15)Å c=10.0594(6)Å
α=90.00° β=104.2860(10)° γ=90.00°
3-Acetyl-4-furyl-1-methylspiro[pyrrolidine-2.2'-indol]-2'(3'H)-one
C18H18N2O3
Acta Crystallographica Section E (2006) 62, 5 o1964-o1965
a=7.7404(6)Å b=10.0227(7)Å c=20.5622(16)Å
α=90.00° β=90.00° γ=90.00°
3-[α-(4-Methoxyphenyl)-β-(4-chlorophenyl)vinyl]-2-methyl-1-phenylsulfonyl- 1H-indole
C30H24ClNO3S
Acta Crystallographica Section E (2005) 61, 7 o2227-o2229
a=13.6402(9)Å b=10.4097(6)Å c=18.4430(11)Å
α=90.00° β=99.7560(10)° γ=90.00°
3-[α-(4-Methoxyphenyl)-β-phenylvinyl]-2-methyl-1-phenylsulfonyl-1H-indole
C30H25NO3S
Acta Crystallographica Section E (2005) 61, 7 o2221-o2223
a=14.8973(11)Å b=8.9581(7)Å c=18.9941(14)Å
α=90.00° β=97.6580(10)° γ=90.00°
2-(2,5-Dimethylbenzyl)-3-phenylsulfanyl-1-phenylsulfonyl-1H-indole
C29H25NO2S2
Acta Crystallographica Section E (2005) 61, 7 o2224-o2226
a=10.8372(6)Å b=17.2384(10)Å c=12.7220(7)Å
α=90.00° β=90.2690(10)° γ=90.00°
2'-Benzoyl-1'-(4-chlorophenyl)-5',6',7',7a'-tetrahydrospiro[indan- 2,3'(2'H)-1H-pyrrolizidine]-1,3-dione
C28H22ClNO3
Acta Crystallographica Section E (2005) 61, 7 o2158-o2160
a=8.2023(5)Å b=11.7111(7)Å c=25.4650(15)Å
α=102.1020(10)° β=90.0140(10)° γ=103.9490(10)°
N-{3-(4-methylphenyl)-6-[(Z)-(4-methylphenyl)methylidene]-2-phenyl- 2-azabicyclo[2.2.2]oct-5-ylidene}aniline
C34H32N2
Acta Crystallographica Section E (2005) 61, 7 o2277-o2279
a=14.1805(8)Å b=10.1822(5)Å c=18.3636(10)Å
α=90.00° β=91.0800(10)° γ=90.00°
[N,N'-Bis(1-{[2-oxido-4-(2-hydroxyethoxy)phenyl]methyl}ethylidene)ethane- 1,2-diamine]copper(II)
C22H26CuN2O6
Acta Crystallographica Section E (2004) 60, 12 m1772-m1774
a=11.8535(7)Å b=8.6424(5)Å c=21.0047(13)Å
α=90.00° β=101.4510(10)° γ=90.00°
N-[(1S,2S,3R)-2-Bromo-3-(tert-butyldiphenylsilyloxy)-1-phenyl-4- (phenylsulfonyl)butyl]-4-methylbenzenesulfonamide
C39H42BrNO5S2Si
Acta Crystallographica Section E (2004) 60, 12 o2290-o2292
a=13.9704(8)Å b=19.5590(12)Å c=14.1646(9)Å
α=90.00° β=96.9000(10)° γ=90.00°
5-(4-nitrophenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C18H18N2O3
Acta Crystallographica Section E (2005) 61, 2 o461-o463
a=9.5001(10)Å b=9.8823(10)Å c=9.9403(10)Å
α=98.039(2)° β=115.157(2)° γ=104.092(2)°
4-(4-nitrophenyl)-2,3,3a,4,5,9b-hexahydro furo[3,2-c]quinoline
C17H16N2O3
Acta Crystallographica Section E (2005) 61, 5 o1419-o1421
a=9.1090(10)Å b=9.2626(10)Å c=9.7553(11)Å
α=103.411(2)° β=102.791(2)° γ=107.081(2)°
1-[2-(2-hydroxyethoxy)ethyl]-4-(dibenzo[b,f][1,4]thiazepin-11- yl)piperazinium hemifumarate
2(C21H26O2N3S),C4H2O42
Acta Crystallographica Section E (2005) 61, 10 o3245-o3248
a=11.9479(8)Å b=13.2197(9)Å c=13.9479(9)Å
α=90.00° β=92.3270(10)° γ=90.00°
3,3-Bis(1H-indol-3-yl)indolin-2-one
C24H17N3O
Acta Crystallographica Section E (2005) 61, 10 o3122-o3123
a=24.0578(12)Å b=10.2342(5)Å c=18.1597(9)Å
α=90.00° β=125.8610(10)° γ=90.00°
4-[Bis(2-methyl-1H-indol-3-yl)methyl]-1-(4-methoxyphenyl)-3-phenylazetidin- 2-one
C35H31N3O2
Acta Crystallographica Section E (2005) 61, 10 o3386-o3388
a=11.9751(7)Å b=13.4815(8)Å c=17.2114(11)Å
α=90.00° β=91.9780(10)° γ=90.00°
1'-nitro-2'-phenyl-2',3',4',5',6',7'-hexahydro-1H-indole- 3-spiro-3'-1'H-pyrrolizin-2(3H)-one
C20H19N3O3
Acta Crystallographica Section E (2005) 61, 10 o3312-o3314
a=23.8981(15)Å b=7.5886(4)Å c=19.1370(10)Å
α=90.00° β=102.941(2)° γ=90.00°
3-(4-Bromophenyl)-6-(p-tosyl)perhydrothiazolidino[3,4-a]pyrrolo[4,5-c]pyrrole
C21H23BrN2O2S2
Acta Crystallographica Section E (2006) 62, 6 o2146-o2148
a=15.3215(8)Å b=8.0676(4)Å c=17.1663(9)Å
α=90.00° β=100.1190(10)° γ=90.00°
11,18-Diphenoxy-3,26-dioxa-13,16- diazahexacyclo[26.2.2.0^4,9^.0^10,13^.0^16,19^.0^20,25^]dotriaconta- 1(31),4,6,8,20,22,24,28(32),29-nonaene-12,17-dione
C40H34N2O6
Acta Crystallographica Section E (2006) 62, 7 o3082-o3084
a=8.3548(6)Å b=18.1540(13)Å c=22.0663(16)Å
α=90.00° β=90.5280(10)° γ=90.00°
Spiro- [2 -3'] oxindole - spiro -[3- 3"] oxindole - 4[p-methyl benzydy] pyrolidizine.
C29H25N3O3
Acta Crystallographica Section E (2003) 59, 10 o1458-o1460
a=9.7632(6)Å b=10.3841(7)Å c=11.6874(8)Å
α=99.7350(10)° β=96.4800(10)° γ=98.8920(10)°
30,31-Dimethyl-3,26-dioxa-11,18- diazapentacyclo[26.4.0.0^4,9^.0^12,17^.0^20,25^]dotriconta- 1(32),4,6,8,12,14,16,20,22,24,28,30-dodecaene-10,19-dione
C30H26N2O4
Acta Crystallographica Section E (2003) 59, 9 o1429-o1431
a=15.5767(9)Å b=15.7746(9)Å c=20.5721(12)Å
α=90.00° β=102.5410(10)° γ=90.00°
2'-Benzoyl-1',2,2',3,4',5',6',6a'-octahydro-1H-indan-2-spiro-3'- (3'H-pyrrolizine)-1'-spiro-3''-1H-indoline-1,2'',3-trione
C29H22N2O4
Acta Crystallographica Section E (2003) 59, 10 o1559-o1561
a=13.1419(10)Å b=12.5844(9)Å c=14.0110(11)Å
α=90.00° β=100.601(2)° γ=90.00°
2'-(p-Methoxybenzoyl)-1',2,2',3,5',6',7',7a'-octahydro-1H-indan-2-spiro-3'- (3'H-pyrrolizine)-1'-spiro-3''-1H-indoline-1,2'',3-trione
C30H24N2O5
Acta Crystallographica Section E (2003) 59, 11 o1783-o1785
a=11.4931(8)Å b=13.6374(9)Å c=15.5377(10)Å
α=90.00° β=96.3510(10)° γ=90.00°
C23H24N2O3
C23H24N2O3
Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 10 o1438-o1440
a=6.3317(5)Å b=11.5470(8)Å c=14.1402(10)Å
α=72.2400(10)° β=77.3660(10)° γ=77.7730(10)°
C-halogen...π interaction: 4-Chloro-2-(9-ethylcarbazol-3-yl)quinoline-1(2H)- carbaldehyde.
C24H19ClN2O
Acta Crystallographica Section E (2003) 59, 10 o1564-o1566
a=9.4147(8)Å b=9.6714(8)Å c=11.1245(9)Å
α=85.3360(10)° β=70.2350(10)° γ=84.351(2)°
C31H28N2O3
C31H28N2O3
Acta Crystallographica Section E (2003) 59, 11 o1680-o1681
a=14.3186(11)Å b=9.6801(7)Å c=17.9616(13)Å
α=90.00° β=91.1900(10)° γ=90.00°
1,2,3,4-Tetrahydro-4'-furfuryl-1'-methylnaphthene-2-spiro-3'-pyrrolidine-2'- spiro-1''-acenaphthene-1,2''-dione
C29H23NO3
Acta Crystallographica Section E (2003) 59, 12 o1875-o1877
a=11.9109(7)Å b=11.3292(7)Å c=17.3573(10)Å
α=90.00° β=103.9930(10)° γ=90.00°
5''-Benzylidene-1'-methyl-4'-phenylindole-3-spiro-2'-pyrrolidine-3'-spiro-3''- piperidine-2(3H),4''-dione
C30H29N3O2
Acta Crystallographica Section E (2003) 59, 12 o1878-o1880
a=10.6889(7)Å b=18.9025(12)Å c=12.5270(8)Å
α=90.00° β=95.2830(10)° γ=90.00°
Dimethyl 1-(7-acetoxy-4-methyl-2-oxo-2H-chromen-8-ylmethyl)-1H-pyrazole- 3,4-dicarboxylate
C20H18N2O8
Acta Crystallographica Section E (2004) 60, 6 o961-o963
a=23.1233(17)Å b=12.7597(9)Å c=15.2076(11)Å
α=90.00° β=116.0320(10)° γ=90.00°
4'-(4-Methoxybenzoyl)-1'-methyl-acenaphthene-1-spiro-2'-pyrrolidine- 3'-spiro-3''-1H-indole-2,2''(1H,3''H)-dione hemihydrate
C31H24N2O4,0.5H2O
Acta Crystallographica Section E (2004) 60, 6 o1003-o1005
a=25.647(2)Å b=10.0538(9)Å c=21.0859(18)Å
α=90.00° β=111.933(2)° γ=90.00°
N-(4-Acetylphenyl)-N'-[(4-sydnone-3-yl)phenyl]urea dimethylformamide solvate
C17H14N4O4,C3H7NO
Acta Crystallographica Section E (2004) 60, 6 o1015-o1016
a=7.7954(8)Å b=8.3922(8)Å c=16.9225(17)Å
α=79.057(2)° β=84.267(2)° γ=65.049(2)°
DL-Valine--succinic acid (2/1)
2C5H11NO2,C4H6O4
Acta Crystallographica Section E (2004) 60, 6 o1009-o1011
a=24.373(2)Å b=7.5744(6)Å c=10.0284(9)Å
α=90.00° β=106.134(2)° γ=90.00°
4-methoxy-12-methyl-12-azatetracyclo[9.3^1.10^.0^2.7^] heptadeca-2(7),3,5-triene
C18H25NO
Acta Crystallographica Section E (2005) 61, 7 o2071-o2073
a=14.0356(12)Å b=15.0658(13)Å c=7.1354(6)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2,2''-dioxo-2,3,5,6,7,7a-hexahydroacenaphthene- 1-spiro-3'-1'H-pyrrolizine-2'spiro-1''-acenaphthene-1-carboxylate
C32H25NO4
Acta Crystallographica Section E (2005) 61, 7 o2267-o2269
a=14.8348(12)Å b=11.1902(9)Å c=16.0909(13)Å
α=90.00° β=112.4790(10)° γ=90.00°
2-Ethyl 3,4-dimethyl 4'-methylbiphenyl-2,3,4-tricarboxylate
C20H20O6
Acta Crystallographica Section E (2005) 61, 10 o3339-o3341
a=6.7650(6)Å b=23.8952(19)Å c=12.0094(10)Å
α=90.00° β=105.6700(10)° γ=90.00°
N-{2,3-diphenyl-6-[(Z)-phenylmethylidene]- 2-azabicyclo[2.2.2]oct-5-ylidene}-aniline
C32H28N2
Acta Crystallographica Section E (2005) 61, 10 o3273-o3275
a=14.6209(13)Å b=9.5899(9)Å c=17.9541(16)Å
α=90.00° β=107.701(2)° γ=90.00°
Methyl 11,2,3,3a-5a-hydroxy-1-methyl-10-oxo-4-phenyl 10H-indeno[1,2-b]furo[3,4-b]pyrrole-3a-carboxylate
C22H21NO5
Acta Crystallographica Section E (2005) 61, 10 o3383-o3385
a=8.6216(5)Å b=10.3055(6)Å c=11.7758(6)Å
α=79.4620(10)° β=79.3770(10)° γ=68.8760(10)°
3-Benzylidene-3',7'-diphenylcyclohexanespiro-6'-(perhydro-2-thiapyrrolizine)- 5'-spiro-3''-1H-indole-2,2''-dione
C37H32N2O2S
Acta Crystallographica Section E (2006) 62, 6 o2259-o2260
a=10.0312(6)Å b=20.8599(13)Å c=14.1305(8)Å
α=90.00° β=100.9730(10)° γ=90.00°
2-(p-Bromophenyl)-5-(benzenesulfonyl)perhydrothiazolidine[3,4-a]pyrrolo[4,5-c] pyrrole
C20H21BrN2O2S2
Acta Crystallographica Section E (2006) 62, 6 o2429-o2431
a=10.5926(6)Å b=11.4144(6)Å c=16.6896(9)Å
α=90.00° β=94.1020(10)° γ=90.00°
Acenapthene-2-spiro-5'-perhydrodipyrrole[1,2-a;2',1'-c]pyrazine-6'- spiro-2''-acenapthene-1,1''-dione
C32H26N2O2
Acta Crystallographica Section E (2006) 62, 6 o2432-o2434
a=8.8721(7)Å b=10.7042(8)Å c=14.2846(11)Å
α=109.4180(10)° β=100.5840(10)° γ=102.4470(10)°
16-[4-(3-Chloropropoxy)-3-methoxybenzylidene]-4-androstene-3,17-dione
C30H37Cl1O4
Acta Crystallographica Section E (2006) 62, 6 o2190-o2192
a=8.0046(4)Å b=17.4763(9)Å c=19.6133(10)Å
α=90.00° β=90.00° γ=90.00°
2,6-Bis(4-methoxyphenyl)-1-nitroso-3,5-diphenylpiperidin-4-one
C31H28N2O4
Acta Crystallographica Section E (2005) 61, 2 o359-o361
a=10.8364(8)Å b=19.4649(15)Å c=12.6722(10)Å
α=90.00° β=103.9260(10)° γ=90.00°
15,18-dimethyl-5-dioxo-14- oxapentacyclo[11.4.1.0^2,15^.0^4,13^.0^6,11^]octadeca-3,6,8,10-tetraene- 18-carbaldehyde
C20H18O4
Acta Crystallographica Section E (2005) 61, 2 o494-o496
a=13.3078(19)Å b=7.9299(11)Å c=15.168(2)Å
α=90.00° β=90.00° γ=90.00°
8a,13b-cis-8,8,13-Trimethyl-11-phenyl-8,8a,9,13b- tetrahydropyrazolo[3'',4''-b']thiapyrano[5',4':3,4]pyrano[5,6-c]coumarin
C25H22N2O3S
Acta Crystallographica Section E (2004) 60, 11 o2155-o2156
a=10.1017(11)Å b=10.2760(12)Å c=20.187(2)Å
α=90.00° β=95.278(2)° γ=90.00°
3'-(2-Chlorophenyl)-1'-methyl-4'nitrospiro[indan-2, 2'-pyrrolidine]-1,3-dione
C19H15ClN2O4
Acta Crystallographica Section E (2004) 60, 11 o2157-o2159
a=13.0966(12)Å b=8.6225(8)Å c=15.7306(14)Å
α=90.00° β=100.0450(10)° γ=90.00°
1,2-Bis(2,4-dinitrophenoxy)ethane
C14H10N4O10
Acta Crystallographica Section E (2004) 60, 11 o2056-o2058
a=6.88760(10)Å b=13.92890(10)Å c=16.5396(5)Å
α=90.00° β=95.146(3)° γ=90.00°
4'-methoxy-4-methoxycarbonyl-2,6-dinitrostilbene
C17H14N2O7
Acta Crystallographica Section E (2004) 60, 11 o2053-o2055
a=12.0496(8)Å b=7.0295(5)Å c=19.8296(13)Å
α=90.00° β=100.8560(10)° γ=90.00°
Ethyl 3-methyl-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate
C13H12N4O6
Acta Crystallographica Section E (2003) 59, 11 o1835-o1837
a=7.7531(8)Å b=9.7146(10)Å c=11.4051(12)Å
α=113.649(2)° β=92.989(2)° γ=109.089(2)°
Dimethyl 3-benzoyl-7-(N,N-dimethylamino)indolizine-1,2-dicarboxylate
C21H20N2O5
Acta Crystallographica Section E (2004) 60, 4 o479-o480
a=8.6333(9)Å b=27.515(3)Å c=7.9705(9)Å
α=90.00° β=99.781(2)° γ=90.00°
Dimethyl 7-(N,N-dimethylamino)3-(4-methylbenzoyl)indolizine-1,2-dicarboxylate
C22H22N2O5
Acta Crystallographica Section E (2004) 60, 4 o537-o538
a=8.050(5)Å b=16.942(11)Å c=17.094(11)Å
α=118.555(10)° β=95.033(12)° γ=97.082(11)°